| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Sorafenib | FAERS: 3 | US FAERS | |
| 2 | Ethylene Glycol | FAERS: 2 | US FAERS | |
| 3 | Ibuprofen | FAERS: 2 | US FAERS | |
| 4 | Azathioprine | FAERS: 1 | US FAERS | |
| 5 | Cabozantinib S-malate | FAERS: 1 | US FAERS | |
| 6 | Ceftriaxone | FAERS: 1 | US FAERS | |
| 7 | Lapatinib | FAERS: 1 | US FAERS | |
| 8 | MDV 3100 | FAERS: 1 | US FAERS | |
| 9 | Miconazole | FAERS: 1 | US FAERS | |
| 10 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 11 | Solifenacin Succinate | FAERS: 1 | US FAERS | |
| 12 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 13 | Vortioxetine hydrobromide | FAERS: 1 | US FAERS | |
| 14 | oxybutynin | FAERS: 1 | US FAERS | |
| 15 | regorafenib | FAERS: 1 | US FAERS | |
| 16 | sofosbuvir-velpatasvir drug combination | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.